Literature DB >> 9645500

Defects of lipoprotein metabolism in familial combined hyperlipidaemia.

J de Graaf1, A F Stalenhoef.   

Abstract

Familial combined hyperlipidaemia is the most common inherited hyperlipidaemia and is found in up to 10% of patients with premature myocardial infarction. The genetic and metabolic bases of the disorder have not yet been defined. This review discusses the important advances in the past year in our understanding of the different metabolic pathways contributing to the pathogenesis of familial combined hyperlipidaemia.

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9645500     DOI： 10.1097/00041433-199806000-00002

Source DB:  PubMed          Journal:  Curr Opin Lipidol        ISSN： 0957-9672            Impact factor:   4.776


  9 in total

Review 1.  Role of lipid-lowering pharmacotherapy in children.

Authors:  S Tonstad
Journal:  Paediatr Drugs       Date:  2000 Jan-Feb       Impact factor: 3.022

Review 2.  Metabolic pathogenesis of familial combined hyperlipidaemia with emphasis on insulin resistance, adipose tissue metabolism and free fatty acids.

Authors:  Jacqueline de Graaf; Mario J Veerkamp; Anton F H Stalenhoef
Journal:  J R Soc Med       Date:  2002       Impact factor: 5.344

3.  Genomewide scan for familial combined hyperlipidemia genes in finnish families, suggesting multiple susceptibility loci influencing triglyceride, cholesterol, and apolipoprotein B levels.

Authors:  P Pajukanta; J D Terwilliger; M Perola; T Hiekkalinna; I Nuotio; P Ellonen; M Parkkonen; J Hartiala; K Ylitalo; J Pihlajamäki; K Porkka; M Laakso; J Viikari; C Ehnholm; M R Taskinen; L Peltonen
Journal:  Am J Hum Genet       Date:  1999-05       Impact factor: 11.025

4.  Triacylglycerol-rich lipoproteins alter the secretion, and the cholesterol-effluxing function, of apolipoprotein E-containing lipoprotein particles from human (THP-1) macrophages.

Authors:  E M Lindholm; A M Palmer; A Graham
Journal:  Biochem J       Date:  2001-06-01       Impact factor: 3.857

5.  Drug therapy of hypercholesterolaemia in children and adolescents.

Authors:  Marjet J A M Braamskamp; Frits A Wijburg; Albert Wiegman
Journal:  Drugs       Date:  2012-04-16       Impact factor: 9.546

Review 6.  Genetics of familial combined hyperlipidemia.

Authors:  P Pajukanta; K V Porkka
Journal:  Curr Atheroscler Rep       Date:  1999-07       Impact factor: 5.967

Review 7.  Common mutations of the lipoprotein lipase gene and their clinical significance.

Authors:  S Gehrisch
Journal:  Curr Atheroscler Rep       Date:  1999-07       Impact factor: 5.967

Review 8.  Management of hypercholesterolemia in children.

Authors:  Marjet J A M Braamskamp; Barbara A Hutten; Albert Wiegman; John J P Kastelein
Journal:  Paediatr Drugs       Date:  2014-04       Impact factor: 3.930

9.  APOE and KLF14 genetic variants are sex-specific for low high-density lipoprotein cholesterol identified by a genome-wide association study.

Authors:  Ying-Hui Lee; Ya-Sian Chang; Chih-Chang Hsieh; Rong-Tsorng Wang; Jan-Gowth Chang; Chung-Jen Chen; Shun-Jen Chang
Journal:  Genet Mol Biol       Date:  2022-02-21       Impact factor: 1.771
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.